Search Results 2011-2020 of 20067 for Receptor
Patients must not have prior or current use of selective estrogen receptor modulators (SERMs) or aromatase inhibitors (AIs). NOTE: The following are ...
Any PAH-specific drug therapy (e.g., any ERA, PDE-5i, soluble guanylate cyclase stimulator, prostacyclin, prostacyclin analog, or prostacyclin receptor ...
... receptor (CAR)-positive T cell therapy, in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in pediatric or adolescent subjects.
Perioperative bleeding in a patient given glycoprotein IIb/IIIa receptor inhibitors.Midwest Anesthesia Residents' Conference. 1999. Third Prize: Sprung J ...
Blood pressure medicines. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin 2 receptor blockers (ARBs) can help lower blood pressure and reduce the ...
Only for the 1L Cohort: human epidermal growth factor receptor 2 (HER2)-negative tumors;; Measurable disease (at least one target lesion) according to ...
Prior or ongoing treatment with GLP-1 receptor agonists; Ongoing treatment with dipeptidyl peptide-IV inhibitors (1 week washout required); Ongoing treatment ...
"It's called fezolinetant, a neurokinin 3 receptor antagonist. It works in the brain to treat hot flashes and night sweats." Fezolinetant is the generic ...
... receptor antibody encephalitis, Progressive multifocal leukoencephalopathy, Autoimmune encephalitis, Meningoencephalitis, Neurosarcoidosis, Myelopathy, Myelitis.
The purpose of this study is to evaluate the safety and tolerability of VGL101 for the treatment of adult-onset leukoencephalopathy with axonal spheroids and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!